(Q48673004)

14 February 2018

title

¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas. (English)

1 reference

14 February 2018

positron emission tomography

main subject

1 reference

1 reference

7

1 reference

14 February 2018

author name string

Kenji Hirata

1

1 reference

14 February 2018

Shunsuke Terasaka

2

1 reference

14 February 2018

Tohru Shiga

3

1 reference

14 February 2018

Naoya Hattori

4

1 reference

14 February 2018

Keiichi Magota

5

1 reference

14 February 2018

Hiroyuki Kobayashi

6

1 reference

14 February 2018

Kiyohiro Houkin

8

1 reference

14 February 2018

Shinya Tanaka

9

1 reference

14 February 2018

Yuji Kuge

10

1 reference

14 February 2018

Nagara Tamaki

11

1 reference

14 February 2018

publication date

4 February 2012

1 reference

14 February 2018

number of pages

11

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

14 February 2018

volume

39

1 reference

14 February 2018

issue

5

1 reference

14 February 2018

page(s)

760-770

1 reference

14 February 2018

https://scigraph.springernature.com/pub.10.1007/s00259-011-2037-0

exact match

0 references

cites work

The 2007 WHO classification of tumours of the central nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Primary brain tumours in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

A proposed grading system for arteriovenous malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Extent of resection in malignant gliomas: a critical summary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Assessing tumor angiogenesis using macromolecular MR imaging contrast media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Prediction of pathology and survival by FDG PET in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Hypoxia is important in the biology and aggression of human glial brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

The interactions of polarographic measurements of oxygen tension and histological grade in human glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Fully automated synthesis of [18F]fluoromisonidazole using a conventional [18F]FDG module

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Fully automated one-pot synthesis of [18F]fluoromisonidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2037-0

Non-invasive PET and SPECT imaging of tissue hypoxia using isotopically labeled 2-nitroimidazoles.

21 January 2018

1 reference

12 December 2020

Anatomic standardization: linear scaling and nonlinear warping of functional brain images.

1 reference

12 December 2020

Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells

1 reference

12 December 2020

Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.

1 reference

12 December 2020

Characteristics of the binding of labeled fluoromisonidazole in cells in vitro

1 reference

12 December 2020

Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies

1 reference

12 December 2020

A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET

1 reference

12 December 2020

Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole

1 reference

12 December 2020

Enhanced binding of the hypoxic cell marker [3H]fluoromisonidazole in ischemic myocardium.

1 reference

12 December 2020

Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.

1 reference

12 December 2020

Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia

1 reference

12 December 2020

10.1007/S00259-011-2037-0

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018